New hope to keep aggressive cancer at bay after initial treatment
Disease control
Recruiting now
This study is testing whether a drug called chidamide can help prevent a type of aggressive blood cancer (DLBCL) from coming back in patients who also have hepatitis B. It is for people whose cancer initially responded well to standard chemotherapy. The goal is to see if taking c…
Phase: PHASE3 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC